• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无导线起搏:现状与持续进展

Leadless Pacing: Current Status and Ongoing Developments.

作者信息

Trohman Richard G

机构信息

Section of Electrophysiology, Division of Cardiology, Department of Internal Medicine, Rush University Medical Center, 1653 W. Congress, Chicago, IL 60612, USA.

出版信息

Micromachines (Basel). 2025 Jan 14;16(1):89. doi: 10.3390/mi16010089.

DOI:10.3390/mi16010089
PMID:39858744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11767621/
Abstract

Although significant strides have been made in cardiac pacing, the field is still evolving. While transvenous permanent pacing is highly effective in the management of bradyarrhythmias, it is not risk free and may result in significant morbidity and, rarely, mortality. Transvenous leads are often the weakest link in a pacing system. They may dislodge, fracture, or suffer breaches in their insulation. This review was undertaken to clarify leadless risks, benefits, and alternatives to transvenous cardiac pacing for bradyarrhythmias and heart failure management. In order to clarify the role(s) of leadless pacing, this narrative review was undertaken by searching MEDLINE to identify peer-reviewed clinical trials, randomized controlled trials, meta-analyses, and review articles, as well as other clinically relevant reports and studies. The search was limited to English-language reports published between 1932 and 2024. Leadless pacing was searched using the terms Micra™, Nanostim™, AVEIR™, single-chamber leadless pacemaker, dual-chamber leadless pacemaker, cardiac resynchronization therapy (CRT), cardiac physiological pacing (CPP) and biventricular pacing (BiV). Google and Google Scholar, as well as bibliographies of identified articles were also reviewed for additional references. The advantages and limitations of leadless pacing as well as options that are under investigation are discussed in detail.

摘要

尽管心脏起搏技术已取得显著进展,但该领域仍在不断发展。经静脉永久起搏在缓慢性心律失常的治疗中非常有效,但并非没有风险,可能导致严重的发病情况,甚至极少情况下会导致死亡。经静脉导线往往是起搏系统中最薄弱的环节。它们可能会移位、断裂或绝缘层破损。本综述旨在阐明无导线起搏在治疗缓慢性心律失常和心力衰竭方面的风险、益处以及经静脉心脏起搏的替代方案。为了阐明无导线起搏的作用,本叙述性综述通过检索MEDLINE来识别同行评审的临床试验、随机对照试验、荟萃分析和综述文章,以及其他临床相关报告和研究。检索仅限于1932年至2024年发表的英文报告。使用术语Micra™、Nanostim™、AVEIR™、单腔无导线起搏器、双腔无导线起搏器、心脏再同步治疗(CRT)、心脏生理性起搏(CPP)和双心室起搏(BiV)来检索无导线起搏相关内容。还对谷歌和谷歌学术以及已识别文章的参考文献进行了审查以获取更多参考文献。本文详细讨论了无导线起搏的优点和局限性以及正在研究的选项。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25d/11767621/907fdd04078b/micromachines-16-00089-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25d/11767621/c4741cb55103/micromachines-16-00089-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25d/11767621/15a51192d443/micromachines-16-00089-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25d/11767621/9b1102321854/micromachines-16-00089-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25d/11767621/bfbc07d4502e/micromachines-16-00089-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25d/11767621/149205035786/micromachines-16-00089-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25d/11767621/907fdd04078b/micromachines-16-00089-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25d/11767621/c4741cb55103/micromachines-16-00089-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25d/11767621/15a51192d443/micromachines-16-00089-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25d/11767621/9b1102321854/micromachines-16-00089-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25d/11767621/bfbc07d4502e/micromachines-16-00089-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25d/11767621/149205035786/micromachines-16-00089-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25d/11767621/907fdd04078b/micromachines-16-00089-g006.jpg

相似文献

1
Leadless Pacing: Current Status and Ongoing Developments.无导线起搏:现状与持续进展
Micromachines (Basel). 2025 Jan 14;16(1):89. doi: 10.3390/mi16010089.
2
Leadless cardiac pacing systems: current status and future prospects.无导线心脏起搏系统:现状与未来展望。
Expert Rev Med Devices. 2019 Nov;16(11):923-930. doi: 10.1080/17434440.2019.1685870.
3
Pacing Without Wires: Leadless Cardiac Pacing.无导线起搏:无导线心脏起搏
Ochsner J. 2016 Fall;16(3):238-42.
4
Leadless Pacemakers: State of the Art and Future Perspectives.无导线起搏器:现状与未来展望。
Card Electrophysiol Clin. 2018 Mar;10(1):17-29. doi: 10.1016/j.ccep.2017.11.003.
5
Two Is Better than One: Aveir DR Leadless Pacemaker System with Dual-Chamber Pacing.两个比一个好:具有双腔起搏功能的Aveir DR无导线起搏器系统
J Cardiothorac Vasc Anesth. 2025 Jan;39(1):286-291. doi: 10.1053/j.jvca.2024.10.020. Epub 2024 Oct 18.
6
Biventricular pacing (cardiac resynchronization therapy): an evidence-based analysis.双心室起搏(心脏再同步治疗):基于证据的分析。
Ont Health Technol Assess Ser. 2005;5(13):1-60. Epub 2005 Sep 1.
7
Outcomes of leadless pacemaker implantation after cardiac surgery and transcatheter structural valve interventions.心脏手术后及经导管结构性瓣膜介入治疗后无导线起搏器植入的结果。
J Cardiovasc Electrophysiol. 2023 Nov;34(11):2216-2222. doi: 10.1111/jce.16074. Epub 2023 Sep 20.
8
Leadless biventricular left bundle and endocardial lateral wall pacing versus left bundle only pacing in left bundle branch block patients.无导线双心室左束支及心内膜侧壁起搏与单纯左束支起搏在左束支传导阻滞患者中的比较
Front Physiol. 2022 Dec 14;13:1049214. doi: 10.3389/fphys.2022.1049214. eCollection 2022.
9
Leadless Pacemakers: State of the Art and Selection of the Ideal Candidate.无导线起搏器:现状与理想患者选择。
Curr Cardiol Rev. 2023;19(5):43-50. doi: 10.2174/1573403X19666230331094647.
10
Emerging Technologies in Electrophysiology: From Single-Chamber to Biventricular Leadless Pacemakers.电生理学中的新兴技术:从单腔到双腔无导线起搏器。
Cardiology. 2022;147(2):179-190. doi: 10.1159/000521976. Epub 2022 Jan 17.

本文引用的文献

1
Ten Years of Leadless Cardiac Pacing.无导线心脏起搏的十年历程
J Am Coll Cardiol. 2024 Nov 19;84(21):2131-2147. doi: 10.1016/j.jacc.2024.08.077.
2
Leadless pacemaker implantation via the internal jugular vein.经颈内静脉植入无导线起搏器。
Europace. 2024 Aug 3;26(8). doi: 10.1093/europace/euae199.
3
A Modular Communicative Leadless Pacing-Defibrillator System.一种模块化的通讯型无导线起搏除颤器系统。
N Engl J Med. 2024 Oct 17;391(15):1402-1412. doi: 10.1056/NEJMoa2401807. Epub 2024 May 18.
4
Pacemaker syndrome: Thinking beyond atrioventricular dyssynchrony.起搏器综合征:超越房室不同步的思考。
HeartRhythm Case Rep. 2024 Feb 4;10(4):273-275. doi: 10.1016/j.hrcr.2024.01.012. eCollection 2024 Apr.
5
Leadless pacemakers at 5-year follow-up: the Micra transcatheter pacing system post-approval registry.5 年随访的无导线起搏器:Micra 经导管起搏系统上市后注册研究。
Eur Heart J. 2024 Apr 7;45(14):1241-1251. doi: 10.1093/eurheartj/ehae101.
6
Leadless Pacemakers: Current Achievements and Future Perspectives.无导线起搏器:当前成果与未来展望
Eur Cardiol. 2023 Aug 18;18:e49. doi: 10.15420/ecr.2022.32. eCollection 2023.
7
2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure.2023 年 HRS/APHRS/LAHRS 心脏生理起搏指南:预防和减轻心力衰竭。
Heart Rhythm. 2023 Sep;20(9):e17-e91. doi: 10.1016/j.hrthm.2023.03.1538. Epub 2023 May 20.
8
A Dual-Chamber Leadless Pacemaker.双腔无导线起搏器。
N Engl J Med. 2023 Jun 22;388(25):2360-2370. doi: 10.1056/NEJMoa2300080. Epub 2023 May 20.
9
How to implant leadless pacemakers and mitigate major complications.如何植入无导线起搏器并减少主要并发症。
Heart Rhythm. 2023 May;20(5):754-759. doi: 10.1016/j.hrthm.2023.01.025. Epub 2023 Jan 28.
10
Leadless Cardiac Pacing: New Horizons.无导线心脏起搏:新视野
Cardiol Ther. 2023 Mar;12(1):21-33. doi: 10.1007/s40119-022-00288-0. Epub 2022 Nov 22.